PATENT CLAIM ANALYSIS

Application Number: 16315653
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["514", "300000"]

Abstract:
Disclosed are compounds inhibiting the conversion of α-KG to D-2-HG pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat IDH associated diseases, including cancer.

Claim (Index 12):
A method of inhibiting conversion of \u03b1-KG to D-2-HG by using one or more compounds, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof of  claim 1 .

Metadata:
- Claim Count in Document: 19.0
- Percentile: 99.0
- Lexical Diversity: 1.22857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14347481', '15499824', '14037761', '14818009', '14408418']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8304555049868039
- 35 USC 102 Novelty (BERT): 0.5453651881322162
- Combined Prediction Score: 0.8019464733013452
- Mean Citation Score: 410.588458
- Max Citation Score: 423.10645
- Similarity Product: 264.4033999562025

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test